MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241,550 | -50.2% | 24,155 | -38.1% | 1.43% | +115.7% |
| Q2 2023 | $485,155 | +11.8% | 39,031 | +26.0% | 0.66% | +258.9% |
| Q1 2023 | $433,876 | +9.5% | 30,969 | +11.9% | 0.18% | +3.4% |
| Q4 2022 | $396,187 | +30.3% | 27,686 | +132.5% | 0.18% | -17.1% |
| Q3 2022 | $304,000 | +35.1% | 11,907 | +50.1% | 0.22% | +129.8% |
| Q2 2022 | $225,000 | -34.2% | 7,935 | -18.2% | 0.09% | -46.3% |
| Q1 2022 | $342,000 | -50.6% | 9,695 | -41.4% | 0.18% | -74.1% |
| Q4 2021 | $693,000 | -50.6% | 16,551 | -42.1% | 0.68% | -25.6% |
| Q3 2021 | $1,402,000 | – | 28,569 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |